Literature DB >> 9131764

Bayesian and mixed Bayesian/likelihood criteria for sample size determination.

L Joseph1, R du Berger, P Bélisle.   

Abstract

Sample size estimation is a major component of the design of virtually every experiment in medicine. Prudent use of the available prior information is a crucial element of experimental planning. Most sample size formulae in current use employ this information only in the form of point estimates, even though it is usually more accurately expressed as a distribution over a range of values. In this paper, we review several Bayesian and mixed Bayesian/likelihood approaches to sample size calculations based on lengths and coverages of posterior credible intervals. We apply these approaches to the design of an experiment to estimate the difference between two binomial proportions, and we compare results to those derived from standard formulae. Consideration of several criteria can contribute to selection of a final sample size.

Mesh:

Year:  1997        PMID: 9131764     DOI: 10.1002/(sici)1097-0258(19970415)16:7<769::aid-sim495>3.0.co;2-v

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  9 in total

1.  Simple, defensible sample sizes based on cost efficiency.

Authors:  Peter Bacchetti; Charles E McCulloch; Mark R Segal
Journal:  Biometrics       Date:  2008-06       Impact factor: 2.571

2.  Efficient network meta-analysis: a confidence distribution approach.

Authors:  Guang Yang; Dungang Liu; Regina Y Liu; Minge Xie; David C Hoaglin
Journal:  Stat Methodol       Date:  2014-09-01

3.  Comparison of Bayesian Sample Size Criteria: ACC, ALC, and WOC.

Authors:  Jing Cao; J Jack Lee; Susan Alber
Journal:  J Stat Plan Inference       Date:  2009-12-01       Impact factor: 1.111

4.  Case-control studies of gene-environment interaction: Bayesian design and analysis.

Authors:  Bhramar Mukherjee; Jaeil Ahn; Stephen B Gruber; Malay Ghosh; Nilanjan Chatterjee
Journal:  Biometrics       Date:  2010-09       Impact factor: 2.571

5.  Sample size requirements for case-control study designs.

Authors:  M D Edwardes
Journal:  BMC Med Res Methodol       Date:  2001-11-19       Impact factor: 4.615

6.  Sample Size Requirements for Calibrated Approximate Credible Intervals for Proportions in Clinical Trials.

Authors:  Fulvio De Santis; Stefania Gubbiotti
Journal:  Int J Environ Res Public Health       Date:  2021-01-12       Impact factor: 3.390

7.  Remote, real-time expert elicitation to determine the prior probability distribution for Bayesian sample size determination in international randomised controlled trials: Bronchiolitis in Infants Placebo Versus Epinephrine and Dexamethasone (BIPED) study.

Authors:  Jingxian Lan; Amy C Plint; Stuart R Dalziel; Terry P Klassen; Martin Offringa; Anna Heath
Journal:  Trials       Date:  2022-04-11       Impact factor: 2.279

8.  Use of a random effects meta-analysis in the design and analysis of a new clinical trial.

Authors:  Hayley E Jones; A E Ades; Alex J Sutton; Nicky J Welton
Journal:  Stat Med       Date:  2018-09-06       Impact factor: 2.373

9.  Protocol for TRAUMADORNASE: a prospective, randomized, multicentre, double-blinded, placebo-controlled clinical trial of aerosolized dornase alfa to reduce the incidence of moderate-to-severe hypoxaemia in ventilated trauma patients.

Authors:  Julien Pottecher; Eric Noll; Marie Borel; Gérard Audibert; Sébastien Gette; Christian Meyer; Elisabeth Gaertner; Vincent Legros; Raphaël Carapito; Béatrice Uring-Lambert; Erik Sauleau; Walter G Land; Seiamak Bahram; Alain Meyer; Bernard Geny; Pierre Diemunsch
Journal:  Trials       Date:  2020-03-18       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.